News

With biotech stocks broadly having a strong run in 2025, and with more of the year ahead, investors are still looking for ...
Q1 2025 Management View CEO Linda Marban reviewed progress on the Biologics License Application (BLA) for deramiocel, targeting full approval for treating Duchenne muscular dystrophy (DMD) ...